Xeris Biopharma Reports Second Quarter 2023 Financial Results
08.08.2023 - Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced financial results for ...